<html>
<head>PUBMED IDs for THC2</head>
<body bgcolor='#C5F0F2'><h1>THC2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10521306/'>An autosomal dominant thrombocytopenia gene maps to chromosomal region 10p.</a> October 16  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/12890928/'>FLJ14813 missense mutation: a candidate for autosomal dominant thrombocytopenia on human chromosome 10.</a> August 2  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/19041681/'>Gene profiles of a human bronchial epithelial cell line after in vitro exposure to respiratory (non-)sensitizing chemicals: identification of discriminating genetic markers and pathway analysis.</a> December 2  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21211618/'>Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2.</a> February 4  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21467542/'>Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families.</a> September 3  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22102272/'>Thrombocytopenias due to gray platelet syndrome or THC2 mutations.</a> February 4  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24430186/'>Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation.</a> April 8  2014<br></body></html>
